$SLS advancing in the fight against AML with upcoming catalysts. The Phase 3 REGAL trial interim analysis &amp; anticipated topline Phase 2 SLS009 data could provide pivotal insights soon. Prior PRs hint at major developments ahead. Stay tuned. 🧬 #SLS #Oncology #Biotech #AML
#sls
#SLS #SLS #Oncology #Biotech #AML